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Abstract 
Introduction: 
Cannabis use is increasing nationwide. Many states have legalized medical and recreational use 
of cannabis.  This study was undertaken to identify any association between cannabis use and 
chronic pain among ED patients. 
Methods: 
This was a prospective survey study of Emergency Department (ED) patients at Miami Valley 
Hospital, a level 1 trauma center in Dayton, Ohio conducted during June – August 2018. The 
survey included data regarding the frequency of cannabis use, chronic pain, and current mental 
illness. 
Results:  
Three hundred and sixty patients participated in this study.  The majority of respondents were 
white (55%) or African American (42%).  Participants reported a mean triage pain score of 7. 
Nearly 50% of participants suffered from chronic pain.  Twenty-seven percent of participants 
reported cannabis use within the past month. Dividing cannabis use into 4 frequency categories 
(0 days use, 1-2 days use, 3-29 days use, and 30 days use), patients who used cannabis more 
frequently reported higher rates of depression, anxiety, and suicidal thoughts (p<0.01). Over 40% 
of daily cannabis users reported experiencing depression and over 50% reported feeling severely 
anxious. Patients experiencing chronic pain were not more likely to present with substance use. 
However, patients experiencing chronic pain were more likely to experience higher rates of 
depression, anxiety, and suicidal thoughts (p<0.001; Mann Whitney Wilcoxon two-tailed test).  
Conclusions:  
Cannabis use was commonly reported in this patient population.  The prevalence of mental 
illness was high.  Cannabis use was associated with anxiety, depression, and suicidal thoughts.  
Participants with chronic pain were more likely to experience higher rates of depression, anxiety, 
and suicidal thoughts. 
Keywords: Cannabis, anxiety, depression 
  
Introduction/Literature Review  
Medical marijuana use and acceptance have grown in the United States.1  Clinical studies on the 
use and efficacy of cannabis in patients with chronic pain have conflicting results. Some studies 
shows positive effects of cannabis in chronic pain management2, while others show no 
improvement of chronic pain, and do not support its use.3 Although past research suggests 
cannabis being commonly used in people with chronic non-cancer pain, our data shows no 
association between chronic pain and cannabis use in the ED setting.  Multiple research studies 
show strong associations and negative effects between cannabis use and a multitude of 
psychological disorders, most notably anxiety and depression.456 A portion of medical providers 
are now prescribing cannabis use for some of these disorders including anxiety and depression 
with little evidence to support its use.7 
 
Hypothesis/Specific Aims/Research Questions 
This study was undertaken to identify any relationship between cannabis use and pain in patients 
presenting to the Emergency Department, and any association of cannabis use with mental health 
disorders ,such as anxiety and depression.  The null hypothesis was there is no association 
between pain and cannabis use, and no association between cannabis use and anxiety and 
depression.  
 
Methods 
 
This was a prospective patient study of ED patients at Miami Valley Hospital,  a level 1 trauma 
center in Dayton, Ohio. Inclusion criteria included patients age 18 or over, with a triage pain 
score of 1 or greater, who speak English, and not appear in distress.  Patients were identified 
from the ED Tracking Board and approached while in the ED treatment area.  Participation did 
not interfere with medical care.  A survey instrument was developed, based on the The Addiction 
Severity Index (ASI), a validated measurement tool as objectively assess addiction. 8, 9  Data 
collected included frequency of drug and alcohol use, and current mental health illness or 
problems.  Demographics of the patient and interview were recorded, but no identifiable data 
were collected.  Data were entered into an Excel spread sheet.  We compared the self-reported 
pain score to all three categories mentioned above, drugs, alcohol, and psychiatric domains.  
Drug use frequency was reported as median days of use and was compared to the pain 
experienced, or psychological problems experienced.  Spearman correlation coefficients were 
used to examine the strength, direction, and statistical significance of the relationships.   A power 
analysis identified that to detect a medium effect size (rho=0.3 or more) with a two-tailed test, 
5% type I error and 80% power, 84 subjects are needed.  Statistical analysis included Chi square 
test to show if the values compared are significant and show association.  This research study 
was approved  by the Wright State University IRB.   
 
Results 
Among 473 eligible participants, 360 consented to participate (76% participation rate).  The 
majority were either White (54.9%) or African American (42.0%) and the mean age was 40 
(range 18 to 85).  Participants reported an average triage pain score of 7 (range 1 to 10). The 
current episode of pain had a mean duration of 2 days.  In addition, 49.5% of participants 
suffered from chronic pain, including back pain (25%), migraine headache (6%), neck pain (6%), 
and other types of chronic pain (63%).  
 The most common substance reported was alcohol.  Forty-one percent (N = 146) of 
participants reported some alcohol use in the past 30 days, with 8% reporting drinking to 
intoxication (Figure 1).  Cannabis use was also commonly reported.  Twenty-seven percent (N = 
96) of participants reported cannabis use in the past 30 days, with the majority reported use at 
least 3 times (78%) and a minority reporting daily use (33%) (Figure 2).  Other substances 
reported by participants included cocaine (3%; N = 11), amphetamines (2%; N = 6), heroin (1%; 
N = 2), other opiates (18%; N = 64), and other substances (11%; N = 40). 
 The prevalence of mental illness was high.  Within the past 30 days, 34% (N = 122) of 
patients reported experiencing serious anxiety or tension and 27% (N = 96) reported difficulty 
understanding, concentrating, or remembering, and 22% (N = 79) reported serious depression.  
Four percent (N = 11) reported serious thoughts of suicide.  A significant number of participants 
had been treated for mental health as an outpatient (28%; N = 100) or as an inpatient (21%; N = 
77). 
 There was no association between self-reported pain scores and substance use.  Anxiety 
was associated with higher self-reported pain scores ((p = 0.03).  There was no association 
between chronic pain and triage pain scores. 
 Substance use was associated with mental health disorders.  Cocaine and cannabis use 
were independently associated with depression.  Cannabis use was associated with anxiety (p < 
0.002).  Amphetamine use and cannabis use were associated with suicidal thoughts.  Patients 
with depression, anxiety, suicidal thoughts or chronic pain reported significantly more days of 
cannabis use than patients without these conditions (all with p<0.01), but this was not found with 
alcohol use (Table 1). 
 Participants with chronic pain were more likely to experience higher rates of depression, 
anxiety, and suicidal thoughts (p<0.001).  
 
 
Figure 1 
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  No. 
Patients 
Median 
[IQR] 
Days 
Used 
Alcohol 
p-value   Median 
[IQR] 
Days 
Used 
Cannabis 
p-value 
No depression 
Depression 
  
281 
79 
0 [0 – 2] 
0 [0 – 2] 
0.87   0 [0 – 0] 
0 [0 – 18] 
<0.001 
No Anxiety 238 0 [0 – 2] 0.83   0 [0 – 0] <0.001 
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122 0 [0 – 2] 0 [0 – 10] 
No suicidal 
thoughts 
Suicidal 
thoughts 
  
346 
14 
0 [0 – 2] 
2 [0 – 5] 
0.07   0 [0 – 1] 
10 [0 – 23] 
<0.001 
No chronic 
pain 
Chronic pain 
 
182 
178 
0 [0 – 2] 
0 [0 – 2] 
0.40   0 [0 – 0] 
0 [0 – 3] 
0.01 
 
 
Table 1: Data are presented as median number of days [interquartile range, 25th – 75th 
percentile]. P-value from Mann Whitney Wilcoxon two-tailed test.  Statistically significant 
associations were found between marijuana use and depression, anxiety, suicidal thoughts, and 
chronic pain.   
 
Discussion 
The emergency department is potentially an ideal place to identify and intervene for 
substance use disorders, which are currently underdiagnosed.10,11 Two common substances 
abused by the general population presenting to the emergency room are cannabis and alcohol,  
both of which are known to be used for self-medication.12  The acceptance of medical and 
recreational use of cannabis has grown in the general American’s view, with little evidence to 
support its medicinal use and adverse effects.13 A portion of medical providers are now 
prescribing cannabis use for some of these disorders including anxiety and depression.14  Limited 
clinical studies on the use and efficacy of cannabis in chronic pain have demonstrated conflicting 
results. Some studies show positive results,15 while others show no benefit, and do not support its 
use. Although past research suggests Cannabis being commonly used by people with chronic 
non-cancer pain, our data shows no associations between chronic pain and cannabis use in the 
ED setting.16 Multiple research studies show strong associations between cannabis use and a 
multitude of psychological disorders, most notably anxiety and depression.17,18,19  
 Our data show patients who use cannabis more frequently had higher rates of depression, 
anxiety, and suicidal thoughts, As with cannabis, alcohol use showed no significant correlation 
between the triage pain scores, or chronic pain.  Binge drinking and acute alcohol intoxication 
leading to emergency room visits are known to be related to anxiety, depression, and mental 
health disorders in general. 20,21,22 However, our data suggests there are no relationships between 
alcohol use and anxiety and depression.   
Limitations of the current study include the inability to discern the nature of the relationship 
between cannabis use and mental health conditions.  Although we found an association, this does 
not prove causation. Additional studies examining whether cannabis use causes anxiety, 
depression, and suicidal thoughts, or vice versa, is critical before cannabis is prescribed for 
chronic pain or psychological disorders.   Some limitations of this study are that the data 
collected were self-reported.   
In conclusion, cannabis use was associated with anxiety, depression, and suicidal thoughts 
among ED patients.  Our data suggest emergency physicians should be aware of the association 
of cannabis use and abuse in patients with prior diagnosis of anxiety or depression, and vice 
versa, but no higher suspicion relating alcohol use with anxiety or depression.  Screening for 
cannabis use in patients presenting to the emergency department may be an important tool used 
to screen patients for anxiety or depression.  Until robust clinical trials on risks and benefits of 
cannabis and specific compounds isolated from the plant are conducted on the above and other 
conditions and disorders, it is difficult to endorse use of these agents to treat specific medical 
conditions.   
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